robustaflavone

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namerobustaflavone
Drug Alias Namehepatis B chemotherapeutic (MediChem)hepatis B chemotherapeutic (Advanced Life Sciences)ALS-920
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionVirus DNA polymerase inhibitors
TargetsVirus DNA polymerase
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesdeCODE chemistry
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesdeCODE chemistryAdvanced Life Sciences Inc
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A